UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells

Overexpression of oncoproteins is a major cause of treatment failure using current chemotherapeutic drugs. Drug‐induced degradation of oncoproteins is feasible and can improve clinical outcomes in diverse types of cancers. Mortalin‐2 (mot‐2) is a dominant oncoprotein in several tumors, including col...

Descripción completa

Detalles Bibliográficos
Autores principales: Sane, Sanam, Hafner, Andre, Srinivasan, Rekha, Masood, Daniall, Slunecka, John l., Noldner, Collin J., Hanson, Alex D., Kruisselbrink, Taylor, Wang, Xuejun, Wang, Yiyang, Yin, Jun, Rezvani, Khosrow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166003/
https://www.ncbi.nlm.nih.gov/pubmed/30107089
http://dx.doi.org/10.1002/1878-0261.12372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166003/
https://www.ncbi.nlm.nih.gov/pubmed/30107089
http://dx.doi.org/10.1002/1878-0261.12372

Ejemplares similares